| Literature DB >> 23183050 |
G Walter Canonica1, Carlos E Baena-Cagnani, Enrico Compalati, Barbara Bohle, Sergio Bonini, Jean Bousquet, Linda Cox, Antje H Fink-Wagner, Sandra González Díaz, Lars Jacobsen, Giovanni Passalacqua, Ruby Pawankar, Stefan Vieths, Osman Yusuf, Torsten Zuberbier.
Abstract
Aims of the Monaco Charter: (1) to present the current evidence on the efficacy and safety of allergen-specific immunotherapy (SIT) and to address the reasons for its underuse in clinical practice; (2) to develop strategies to increase the awareness about the benefits and the hazards of SIT in allergic patients, lay public and healthcare professionals not trained in allergy, and (3) to make SIT accessible and affordable to eligible patients.Entities:
Mesh：
Substances：
Year: 2012 PMID： 23183050 DOI： 10.1159/000343883
Source DB: PubMed Journal: Int Arch Allergy Immunol ISSN： 1018-2438 Impact factor: 2.749